St. Cloud Capital is pleased to announce an investment in Charlotte, North Carolina-based Catawba Research. St. Cloud has partnered with a financial investment firm focused on control investments in the life sciences and industrial sectors to support Catawba's next phase of growth. It is an investment out of St. Cloud's third fund, which has committed capital […]
Catawba Research is proud to have served as the CRO for Vyome Therapeutics on their successful Phase 2 Trial of VB-1953 for Moderate to Severe Acne. Needless to say, Catawba Research is excited for our client and honored to be by their side. Vyome Therapeutics is a clinical-stage company developing locally-acting, next generation therapeutics for […]
Catawba Research is heading to Washington, D.C. March 1–3 to attend the American Academy of Dermatology (AAD) 2019 Annual Meeting. During our visit, we will be huddling up with site networks, sponsors, and others to discuss their CRO needs in the year ahead and beyond. With more than 26 studies completed in the last five […]
Here is a sample of our latest training video on plaque psoriasis with Dr. Zoe Draelos, a leader in clinical and research dermatology. To learn more about our training program or see some our videos, contact us!
Our latest training video is for tinea pedis. As with all of our training videos, this most recent one is led by a leading expert in the industry and contains extensive technical information specific to the study area / product. After watching our videos, trainees are tested on their retention of the topic. To learn […]
We are pleased to announce the arrival of our latest training video! We have been hard at work developing and filming comprehensive, indication and product-specific training videos for the individual therapeutic areas we’re conducting trials in. Each video is extensive, with more than 30 minutes of technical information specific to that indication or product, as […]
This Friday, Oct. 20, leaders from Catawba Research will be attending an FDA Public Workshop in Silver Spring, MD. The Topic: "Overcoming Barriers to Product Development, Regulatory Approval and Commercialization of Affordable, High Quality, Generic Topical Dermatological Drug Products" The event takes place at the FDA White Oak Campus: 10903 New Hampshire Avenue – building […]
CRO launches efficiency model, focusing on dermatology, women’s health and ophthalmology Over the last three years, Catawba Research has entered the pharmaceutical space to much industry attention. The North Carolina-based, multimillion dollar company has doubled its revenue and the number of studies initiated every six months. Drawing on more than 25 years of experience in […]
Site Relationships When it comes to clinical research, it goes without saying that the relationship between CRO and Sponsor is of utmost importance. Sponsors are footing the bill of the clinical trial and have specific timelines and deliverables that are imperative for success. The most fruitful CRO-Sponsor relationships are built on respect, communication, and collaboration […]
Taking Corporate Responsibility to Heart at Catawba Research Over the past several years, we have witnessed our company, Catawba Research (Catawba), transform into a growing and prosperous CRO. We are very fortunate to experience such success, and as a part of our mission throughout this growth has been to establish a company culture unique to […]
